|
De Rucci Healthy Sleep Co., Ltd. (001323.Sz) DCF -Bewertung
CN | Consumer Cyclical | Furnishings, Fixtures & Appliances | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
De Rucci Healthy Sleep Co., Ltd. (001323.SZ) Bundle
Unser (001323SZ) DCF-Taschenrechner, der für die Genauigkeit entwickelt wurde, ermöglicht es Ihnen, de Rucci Healthy Sleep Co., Ltd. bewertet zu werden, und bietet gleichzeitig Finanzdaten realer Welt und bietet gleichzeitig vollständige Flexibilität, um alle wesentlichen Parameter für erweiterte Projektionen zu ändern.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,862.1 | 4,452.4 | 6,481.0 | 5,812.7 | 5,578.6 | 6,227.2 | 6,951.2 | 7,759.4 | 8,661.5 | 9,668.6 |
| Revenue Growth, % | 0 | 15.29 | 45.56 | -10.31 | -4.03 | 11.63 | 11.63 | 11.63 | 11.63 | 11.63 |
| EBITDA | 502.9 | 774.7 | 1,070.5 | 1,145.2 | 1,223.9 | 1,103.2 | 1,231.4 | 1,374.6 | 1,534.4 | 1,712.8 |
| EBITDA, % | 13.02 | 17.4 | 16.52 | 19.7 | 21.94 | 17.72 | 17.72 | 17.72 | 17.72 | 17.72 |
| Depreciation | 93.7 | 99.6 | 233.0 | 310.7 | 253.7 | 226.1 | 252.3 | 281.7 | 314.4 | 351.0 |
| Depreciation, % | 2.43 | 2.24 | 3.59 | 5.34 | 4.55 | 3.63 | 3.63 | 3.63 | 3.63 | 3.63 |
| EBIT | 409.2 | 675.0 | 837.5 | 834.5 | 970.2 | 877.1 | 979.1 | 1,092.9 | 1,220.0 | 1,361.9 |
| EBIT, % | 10.59 | 15.16 | 12.92 | 14.36 | 17.39 | 14.09 | 14.09 | 14.09 | 14.09 | 14.09 |
| Total Cash | 485.6 | 1,273.8 | 1,423.5 | 2,471.8 | 3,676.7 | 2,136.9 | 2,385.3 | 2,662.7 | 2,972.2 | 3,317.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 144.8 | 106.4 | 144.4 | 192.1 | 42.1 | 154.8 | 172.8 | 192.9 | 215.3 | 240.3 |
| Account Receivables, % | 3.75 | 2.39 | 2.23 | 3.3 | 0.75474 | 2.49 | 2.49 | 2.49 | 2.49 | 2.49 |
| Inventories | 255.5 | 265.3 | 298.9 | 220.2 | 242.7 | 315.4 | 352.1 | 393.0 | 438.7 | 489.7 |
| Inventories, % | 6.62 | 5.96 | 4.61 | 3.79 | 4.35 | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 |
| Accounts Payable | 519.6 | 640.3 | 568.9 | 603.6 | 1,064.9 | 823.1 | 918.8 | 1,025.6 | 1,144.8 | 1,277.9 |
| Accounts Payable, % | 13.45 | 14.38 | 8.78 | 10.38 | 19.09 | 13.22 | 13.22 | 13.22 | 13.22 | 13.22 |
| Capital Expenditure | -369.2 | -456.2 | -768.2 | -621.7 | -395.7 | -615.8 | -687.4 | -767.3 | -856.6 | -956.2 |
| Capital Expenditure, % | -9.56 | -10.25 | -11.85 | -10.7 | -7.09 | -9.89 | -9.89 | -9.89 | -9.89 | -9.89 |
| Tax Rate, % | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 | 16.37 |
| EBITAT | 319.2 | 546.2 | 703.0 | 721.5 | 811.4 | 724.4 | 808.6 | 902.6 | 1,007.6 | 1,124.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 163.0 | 338.8 | 24.9 | 476.1 | 1,258.3 | -92.6 | 414.6 | 462.8 | 516.6 | 576.6 |
| WACC, % | 6.51 | 6.51 | 6.52 | 6.52 | 6.52 | 6.52 | 6.52 | 6.52 | 6.52 | 6.52 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,483.2 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 594 | |||||||||
| Terminal Value | 16,889 | |||||||||
| Present Terminal Value | 12,317 | |||||||||
| Enterprise Value | 13,800 | |||||||||
| Net Debt | -2,364 | |||||||||
| Equity Value | 16,165 | |||||||||
| Diluted Shares Outstanding, MM | 399 | |||||||||
| Equity Value Per Share | 40.50 |
What You Will Receive
- Genuine (001323SZ) Financial Data: Preloaded with De Rucci’s historical and forecasted data for accurate assessments.
- Completely Customizable Template: Easily adjust critical inputs such as revenue growth, WACC, and EBITDA percentage.
- Instant Calculations: Watch as De Rucci’s intrinsic value updates in real-time based on your modifications.
- Expert Valuation Tool: Tailored for investors, analysts, and consultants aiming for precise DCF outcomes.
- Intuitive Design: A straightforward layout with clear guidance suitable for all skill levels.
Highlighted Features
- Customizable Sleep Metrics: Adjust essential parameters like sleep duration, comfort rating, and material quality.
- Instant Sleep Quality Assessment: Provides immediate evaluations of sleep products, ensuring optimal choices.
- High-Precision Standards: Incorporates real-world data from De Rucci Healthy Sleep Co., Ltd. (001323SZ) for accurate product evaluations.
- Simplified Scenario Exploration: Effortlessly analyze various sleep conditions and compare their effectiveness.
- Efficiency Booster: Remove the hassle of creating intricate sleep models from the ground up.
How It Functions
- 1. Access the Template: Download and open the Excel file featuring De Rucci Healthy Sleep Co., Ltd.'s (001323SZ) preloaded data.
- 2. Modify Assumptions: Adjust essential inputs such as growth rates, WACC, and capital expenditures.
- 3. See Results Immediately: The DCF model automatically computes intrinsic value and NPV in real-time.
- 4. Explore Scenarios: Evaluate multiple forecasts to investigate various valuation results.
- 5. Utilize with Assurance: Present expert valuation analyses to enhance your decision-making process.
Why Select This Calculator for De Rucci Healthy Sleep Co., Ltd. (001323SZ)?
- Reliable Data: Leveraging accurate financials from De Rucci for trustworthy valuation outcomes.
- Fully Customizable: Modify essential parameters like growth rates, WACC, and tax rates to align with your projections.
- Efficient: Built-in calculations save you time, allowing you to avoid starting from square one.
- Professional Quality: Tailored for investors, analysts, and financial consultants.
- User-Friendly Interface: Simple design and clear step-by-step guidance make it accessible for all users.
Who Could Benefit from This Product?
- Investors: Assess De Rucci Healthy Sleep Co., Ltd.'s (001323SZ) valuation prior to making investment decisions.
- CFOs and Financial Analysts: Enhance valuation methodologies and evaluate financial forecasts.
- Startup Founders: Discover valuation strategies employed for established companies like De Rucci Healthy Sleep Co., Ltd. (001323SZ).
- Consultants: Provide comprehensive valuation reports to your clients based on industry standards.
- Students and Educators: Utilize actual market data to learn and teach valuation concepts effectively.
Contents of the Template
- Detailed DCF Model: Fully editable template featuring extensive valuation calculations.
- Industry-Specific Data: De Rucci Healthy Sleep Co., Ltd.'s (001323SZ) historical and forecasted financials preloaded for evaluation.
- Adjustable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
- Comprehensive Financial Statements: Complete annual and quarterly breakdowns for enhanced analysis.
- Essential Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Interactive Dashboard with Visual Outputs: Visual representations such as charts and tables for clear, actionable insights.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.